 | |
- close
- close
|
StreetInsider.com
Nov 20
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Ligand+Pharma+%28LGND%29+Reports+Data+on+SARM/5129231.html for the full story.
Business Wire
Nov 20
Comment
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that data from a preclinical study on its selective androgen receptor modulator (SARM) LGD-4033 was featured in a poster presentation at the 62nd Annual Meeting of the Gerontology
Business Wire
Nov 19
Comment
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that it has received $2 million in milestone payments from N. V. Organon, a subsidiary of Merck & Co., Inc., stemming from its research collaboration that is due to expire at the end
StreetInsider.com
Nov 5
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Ligand+Pharma+%28LGND%29+Posts+Q3+Loss+of+3c%2C+Tops+by+1c%3B+Guides/5081271.html for the full story.
Business Wire
Nov 5
Comment
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (the “Company” or “Ligand”) today announced financial results for the three and nine months ended September 30, 2009 and provided a business update. "Over the past few months, we announced
Business Wire
Nov 5
Comment
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that its research collaboration with Pfizer for JAK3 has been extended by one year. The Research and License Agreement entered into in December 2006 with Wyeth provided for an initial
Business Wire
Nov 2
Comment
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has amended its license agreement with Exelixis, Inc. (NASDAQ: EXEL) as a result of which Ligand is now entitled to receive royalties on net sales of future products from a mineralocorticoid receptor
FierceBiotech
Oct 27
Comment
Less than two months after its CEO announced plans to jump ship, Ligand Pharmaceuticals announced a deal to buy the struggling La Jolla, CA-based Metabasis (MBRX) for only $3.2 million in cash--less net liabilities--and contingency value rights...
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
LGND AT A GLANCE
References
| ||||||
|
|
